The North America peripheral vascular devices market is expected to grow from US$ 4,116.66 million in 2021 to US$ 6,522.05 million by 2028; it is estimated to register a CAGR of 6.8% from 2021 to 2028. The three most common cardiovascular diseases (CVDs) across the region are coronary heart disease, cerebrovascular disease, and peripheral artery disease (PAD). Although CVD prevention and control has gained traction in recent decades, efforts and measures were taken that were primarily focused on coronary heart disease and cerebrovascular disease, one of the world's leading causes of mortality. Despite receiving less attention, PAD has emerged as a significant contributor to worldwide deaths and disabilities, with an increasing burden in low-income and middle-income countries (LMICs). A blockage in the blood vessels causes PAD or peripheral vascular disease (PVD), which reduces blood flow to the limbs, most commonly the legs. An arterial embolism occurs when a mass of tissue or a foreign substance moves through the vascular tree and lodges in a distant artery, blocking blood flow. Ischemia, organ failure, and possible infarction result from this blockage. Medical and surgical emergencies, including stroke, acute limb ischemia, mesenteric ischemia, and renal failure, are symptoms of this complex condition. Due to pre-existing factors, such as age, hypercoagulability, cardiac abnormalities, and atherosclerotic disease, surgical and intensive care patients are at a higher risk for arterial embolization. These factors are supporting the peripheral vascular devices market substantially across the region.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America peripheral vascular devices market to grow at a notable CAGR during the forecast period.
North America Peripheral Vascular Devices Market Segmentation
The North America peripheral vascular devices market is segmented into product, end user, and country. Based on product, the North America peripheral vascular devices market is segmented into peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, and embolization guidewires. Further, the peripheral vascular stents segment dominated the market in 2021. Based on end user, the North America peripheral vascular devices market is segmented into hospitals & clinics, ambulatory care centers, specialty clinics, and others. Further, the hospitals & clinics segment dominated the market in 2021. Based on country, the North America peripheral vascular devices market is segmented into the US, Canada, and Mexico. Further, the US dominated the market in 2021.
Abbott, B. Braun Melsungen AG, BD, Boston Scientific Corporation, Cardinal Health Inc, Cook Medical LLC, Edwards Lifesciences Corporation, Medtronic, Teleflex Incorporated, and Terumo Corporation are among the leading companies operating in the North America peripheral vascular devices market.